Gene · 2041
Papers3,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of cell division control protein 42 in tumor and non-tumor diseases: A systematic review. | J Cancer | 2022 | 35154449 | PubTator, text mining | PubMed |
| Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4. | Cell Chem Biol | 2022 | 35148834 | PubTator, text mining | PubMed |
| The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. | Cell Mol Biol Lett | 2022 | 35109786 | PubTator, text mining | PubMed |
| EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma. | Signal Transduct Target Ther | 2022 | 35105853 | PubTator, text mining | PubMed |
| Loss of EphA7 Expression in Basal Cell Carcinoma by Hypermethylation of CpG Islands in the Promoter Region. | Anal Cell Pathol (Amst) | 2022 | 35103233 | PubTator, text mining | PubMed |
| An atlas of dynamic peripheral blood mononuclear cell landscapes in human perioperative anaesthesia/surgery. | Clin Transl Med | 2022 | 35061932 | PubTator, text mining | PubMed |
| The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma. | Life (Basel) | 2022 | 35054466 | PubTator, text mining | PubMed |
| Challenges and Opportunities for the Translation of Single-Cell RNA Sequencing Technologies to Dermatology. | Life (Basel) | 2022 | 35054460 | PubTator, text mining | PubMed |
| Medical students from German-speaking countries on abroad electives in Africa: destinations, motivations, trends and ethical dilemmas. | Hum Resour Health | 2022 | 35039072 | PubTator, text mining | PubMed |
| The Phenotypic and Mutational Spectrum of the FHONDA Syndrome and Oculocutaneous Albinism: Similarities and Differences. | Invest Ophthalmol Vis Sci | 2022 | 35029636 | PubTator, text mining | PubMed |
| Investigating the effects of compound paralogous EPHB receptor mutations on mouse facial development. | Dev Dyn | 2022 | 35025117 | PubTator, text mining | PubMed |
| Challenge accepted: uncovering the role of rare genetic variants in Alzheimer's disease. | Mol Neurodegener | 2022 | 35000612 | PubTator, text mining | PubMed |
| The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects. | Acta Neuropathol Commun | 2022 | 34998435 | PubTator, text mining | PubMed |
| The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery. | Alzheimers Dement | 2022 | 34978149 | PubTator, text mining | PubMed |
| Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells. | Cancer Genomics Proteomics | 2022 | 34949656 | PubTator, text mining | PubMed |
| Genomics and Functional Genomics of Alzheimer's Disease. | Neurotherapeutics | 2022 | 34935119 | PubTator, text mining | PubMed |
| Eph signaling is regulated by miRNA-210: Implications for corneal epithelial repair. | FASEB J | 2022 | 34856019 | PubTator, text mining | PubMed |
| The transcriptome of hand eczema assessed by tape stripping. | Contact Dermatitis | 2022 | 34812515 | PubTator, text mining | PubMed |
| Engineering Tissues of the Central Nervous System: Interfacing Conductive Biomaterials with Neural Stem/Progenitor Cells. | Adv Healthc Mater | 2022 | 34808031 | PubTator, text mining | PubMed |
| Placenta Percreta Presents with Neoangiogenesis of Arteries with Von Willebrand Factor-Negative Endothelium. | Reprod Sci | 2022 | 34766259 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2041/papers?page=30